Results 1 to 10 of about 173,552 (165)

Lymphocyte to C-Reactive Protein Ratio as an Early Biomarker to Distinguish Sepsis from Pneumonia in Neonates [PDF]

Journal of Inflammation Research, 2023
Xinrui Liu,1 Yuan Mu2 1Zhengzhou Key Laboratory of Children’s Infection and Immunity, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou, People’s Republic of China; 2Institute of ...
Liu X, Mu Y
doaj   +4 more sources

Lymphocyte-to-C reactive protein ratio as novel inflammatory marker for predicting outcomes in hemodialysis patients: A multicenter observational study [PDF]

Frontiers in Immunology, 2023
BackgroundPatients undergoing hemodialysis experience inflammation, which is associated with a higher risk of mortality. The lymphocyte-to-C reactive protein ratio (LCR) is a novel marker of inflammation that has been shown to predict mortality in ...
Xinpan Chen, Wang Guo, Zongli Diao, Hongdong Huang, Wenhu Liu   +4 more
doaj   +4 more sources

Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy [PDF]

Journal of Hepatocellular Carcinoma
Zhan Shi,1,* Sihui Zhu,2,* Yuncheng Jin,1 Liang Qi,1 Mingzhen Zhou,1 Ziyan Zhou,1 Juan Zhang,1 Baorui Liu,1 Jie Shen1 1Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University & Clinical ...
Shi Z, Zhu S, Jin Y, Qi L, Zhou M, Zhou Z, Zhang J, Liu B, Shen J   +8 more
doaj   +4 more sources

Relationship between the lymphocyte to C‑reactive protein ratio and coronary artery disease severity. [PDF]

Exp Ther Med, 2023
Coronary atherosclerosis is a chronic systemic inflammatory disease. Laboratory parameters such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and systemic immune inflammation index (SII) have been used to assess inflammation degree and coronary artery disease (CAD) severity.
Chen K, Liu Y, Xu B, Ye T, Chen L, Wu G, Zong G.   +6 more
europepmc   +3 more sources

Preoperative lymphocyte-to-C-reactive protein ratio predicts hepatocellular carcinoma recurrence after surgery. [PDF]

Ann Surg Treat Res, 2022
This study was performed to determine the prognostic value of lymphocyte-to-CRP ratio after curative resection for hepatocellular carcinoma.Between July 2010 and October 2021, 173 consecutive patients (144 male, 29 female) who underwent surgical resection for pathologically confirmed hepatocellular carcinoma were included in this retrospective study ...
Utsumi M, Inagaki M, Kitada K, Tokunaga N, Kondo M, Sakurai Y, Yunoki K, Hamano R, Miyasou H, Tsunemitsu Y, Otsuka S.   +10 more
europepmc   +3 more sources

Lymphocyte-to-C-Reactive Protein Ratio as an Early Sepsis Biomarker for Neonates with Suspected Sepsis. [PDF]

Mediators Inflamm, 2023
Background. Neonatal sepsis is an extremely dangerous and fatal disease among neonates, and its timely diagnosis is critical to treatment. This research is aimed at evaluating the clinical significance of the lymphocyte-to-C-reactive protein ratio (LCR) as an early sepsis indicator in neonates with suspected sepsis. Methods.
Li X, Wei Y, Xu Z, Li T, Dong G, Liu X, Zhu Z, Yang J, Yang J.   +8 more
europepmc   +4 more sources

Lymphocyte to C-reactive protein ratio predicts long-term outcomes for patients with lower rectal cancer. [PDF]

World J Surg Oncol, 2021
Abstract Backgrounds The lymphocyte to C-reactive protein (CRP) ratio (LCR) is an indicator of systemic inflammation and host–tumor cell interactions. The aim of this study was to investigate the prognostic significance of LCR in lower rectal cancer patients who received preoperative chemo-radiotherapy (CRT).
Nishi M, Shimada M, Tokunaga T, Higashijima J, Yoshikawa K, Kashihara H, Takasu C, Ishikawa D, Wada Y, Eto S, Yoshimoto T.   +10 more
europepmc   +5 more sources

Prognostic Value of the Preoperative Lymphocyte-to-C-Reactive Protein Ratio and Albumin-to-Globulin Ratio in Patients with Osteosarcoma. [PDF]

Onco Targets Ther, 2020
Growing evidence indicates that preoperative biomarkers could be identified as independent prognostic factors in various cancers. The purpose of this study was to assess prognostic value of the preoperative lymphocyte-to-C-reactive protein ratio (LCR), albumin-to-globulin ratio (AGR), lymphocyte-monocyte ratio (LMR), and C-reactive protein to albumin ...
Hu H, Deng X, Song Q, Lv H, Chen W, Xing X, Zhu J, Tan Z, Cheng X, Wang B, Shao Z, Zhang Y.   +11 more
europepmc   +6 more sources

Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer. [PDF]

BMC Cancer, 2022
Abstract Background Systemic inflammation is currently regarded as a hallmark of cancer. This study aimed to accurately clarify the prognostic value of various inflammatory markers in patients with stage IV cancer. Methods This study assessed 2,424 patients with cancer ...
Zhang HY, Xie HL, Ruan GT, Zhang Q, Ge YZ, Liu XY, Tang M, Song MM, Lin SQ, Yang M, Zhang XW, Xu HX, Song CH, Shi HP.   +13 more
europepmc   +4 more sources

Prognostic Role of Lymphocyte-to-C-Reactive Protein Ratio in Patients with Pulmonary Arterial Hypertension. [PDF]

J Clin Med
Background: Inflammation plays a critical role in the prognosis of patients with pulmonary arterial hypertension (PAH). The lymphocyte-to-C-reactive protein ratio (LCR), as a novel inflammatory marker, has not been studied in patients with PAH. The objective of this study was to investigate the prognostic value of the LCR in patients with PAH. Methods:
Chen MQ, Wan CX, Tong J, Wang A, Ruan BQ, Shen JY.   +5 more
europepmc   +3 more sources